The programme is successfully functional in 52 centers (49 CHCs and 3 District Hospitals) all 3 identified districts. Till December 2017, 241886 patients have been screened for selected Non Communicable Disease, out of which 54991 patients have been enrolled for selected NCDs under this programme and out of which 23699 Diabetic patients have been enrolled and given treatment, Dietary regimen and Yoga classes.
CCRAS has developed an anti-diabetic formulation namely AYUSH-82 and commercialized to several pharmaceutical companies through National Research Development Corporation (NRDC), New Delhi.
CSIR, has developed after standardization and pre-clinical studies conducted jointly by CSIR-CIMAP and CSIR-NBRI a formulation BGR34, which is meant to be used by patients of newly diagnosed diabetes only as a measure of management of the disease.
This information was given by the Minister of State (Independent Charge) for AYUSH, Shri Shripad Yesso Naik in written reply to a question in Rajya Sabha today.